TPG to Explore Sale of Immucor for Over $2bn

TPG to Explore Sale of Immucor for Over $2bn

Private equity firm TPG is exploring a sale of Immucor, the maker of tests that screen blood before transfusions and organ transplants. TPG is working with an adviser on potential options for the company it took private about a decade ago, the people said, asking not...